ChartRow logo
ELVN
$41.25+6.59%
as of close, Oct 20, 2026
☾ AH $41.25 +6.59%
PeersMRNALLYMDTUNHJNJTMO
Share this page

Enliven Therapeutics Inc. total returns by year (including dividends)

As of market close, Oct 20, 2026

Enliven Therapeutics Inc. total returns by year (2021–2026)#

Enliven Therapeutics Inc. annual returns by year
YearTotal return
2026YTD
+167.9%
2025
-31.6%
2024
+62.6%
2023
+238.4%
2022
+81.8%
2021
-89.8%
Annualized
+15.5%
2021–2026
Average year
+52.3%
5 full years
Best year
+238.4%
2023
Worst year
-89.8%
2021
Positive years
3/5
60% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on ELVN. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Enliven Therapeutics Inc.'s average annual return?
Since 2021, Enliven Therapeutics Inc. (ELVN) has returned about 15.5% a year (the compound annual growth rate) and an average calendar-year return of 52.3%.
What were Enliven Therapeutics Inc.'s best and worst years?
Over 2021–2026, the best year was 2023 (+238.4%) and the worst was 2021 (-89.8%).
How often is Enliven Therapeutics Inc. up in a year?
3 of the 5 full years since 2021 were positive — about 60% of the time.

More on Enliven Therapeutics Inc.